← All trials
NCT05379946
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2022
- Primary completion
- Jun 30, 2024
- Completion date
- Dec 30, 2024
- First posted
- May 18, 2022
- Last posted
- Aug 8, 2022
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- InventisBio Inc.Lead sponsor
- Chinese Academy of Medical SciencesOverall official - principal investigator
- InxMed (Shanghai) Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.